Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Neoplasms × Gefitinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 9 Head and Neck Neoplasms 5 Adenocarcinoma of Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Untreated Childhood Anaplastic Astrocytoma 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Salivary Gland Neoplasms 1 Recurrence 1 Peritoneal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Lymphoid Interstitial Pneumonia 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Laryngeal Diseases 1

Interventions

Leucovorin 4 Irinotecan 4 Fluorouracil 4 Oxaliplatin 3 Bevacizumab 3 cobimetinib 2 Standard of Care 2 Specimen Handling 2 Panitumumab 2 Magnetic Resonance Spectroscopy 2 Ketamine 2 Hydroxychloroquine 2 Cisplatin 2 Capecitabine 2 ulixertinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 sodium thiosulfate 1 rucaparib 1 romiplostim 1 rilotumumab 1 regorafenib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 osimertinib 1 napabucasin 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡